The Cigna Group (CI) FY2024 Q3 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-07-01 to 2024-09-30

Swipe to see the full flow
The Cigna Group cash flow reconciliation, Jul 1, 2024 through Sep 30, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $46,000,000.00Net income → Operating adjustments reconciliation: $779,000,000.00Pharmacy and other service costs payable → Operating adjustments reconciliation: $1,159,000,000.00Realized investment losses, net → Operating adjustments reconciliation: $921,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $650,000,000.00Other, net → Operating adjustments reconciliation: $430,000,000.00Reinsurance recoverable and Other assets → Operating adjustments reconciliation: $201,000,000.00Inventories → Operating adjustments reconciliation: $105,000,000.00Loss on sale of businesses → Operating adjustments reconciliation: $87,000,000.00Operating adjustments reconciliation → Accounts receivable, net: $3,287,000,000.00Operating adjustments reconciliation → Accounts payable and Accrued expenses and other liabilities: $804,000,000.00Operating adjustments reconciliation → Deferred income tax benefit: $152,000,000.00Operating adjustments reconciliation → Insurance liabilities: $89,000,000.00Net change in short-term debt → financing reconciliation: $833,000,000.00Issuance of common stock → financing reconciliation: $62,000,000.00Deposits and interest credited to contractholder deposit funds → financing reconciliation: $36,000,000.00financing reconciliation → Net cash from financing activities: $439,000,000.00financing reconciliation → Common stock dividend paid: $390,000,000.00financing reconciliation → Other, net: $57,000,000.00financing reconciliation → Withdrawals and benefit payments from contractholder deposit funds: $45,000,000.00Net cash used in investing activities → investing reconciliation: $776,000,000.00Debt securities and equity securities → investing reconciliation: $176,000,000.00Debt securities and equity securities → investing reconciliation: $171,000,000.00Other sales, maturities and repayments (primarily short-term and other long-term investments) → investing reconciliation: $116,000,000.00Commercial mortgage loans → investing reconciliation: $42,000,000.00investing reconciliation → Debt securities and equity securities: $450,000,000.00investing reconciliation → Property and equipment purchases, net: $399,000,000.00investing reconciliation → Other (primarily short-term and other long-term investments): $163,000,000.00investing reconciliation → Other, net: $135,000,000.00investing reconciliation → Acquisitions, net of cash acquired: $132,000,000.00investing reconciliation → Commercial mortgage loans: $2,000,000.00Exchange-rate effect → Cash sources and uses: $18,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations → Cash sources and uses: $7,457,000,000.00Net cash from operating activities → Cash sources and uses: $46,000,000.00Net cash from financing activities → Cash sources and uses: $439,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $7,184,000,000.00Cash sources and uses → Net cash used in investing activities: $776,000,000.00Other, net: $430,000,000.00Other working capital, net+$430.00 MAccounts payable and Accrued expenses and other liabilities: -$804,000,000.00Accounts payable and Accrued expenses and otherliabilities−$804.00 MDeferred income tax benefit: -$152,000,000.00Deferred tax balances−$152.00 MDepreciation and amortization: $650,000,000.00Depreciation & amortization+$650.00 MInventories: $105,000,000.00Inventories+$105.00 MNet income: $825,000,000.00Net income+$825.00 MInsurance liabilities: -$89,000,000.00Insurance liabilities−$89.00 MAccounts receivable, net: -$3,287,000,000.00Accounts & other receivables−$3.29 BRealized investment losses, net: $921,000,000.00Realized investment losses, net+$921.00 MPharmacy and other service costs payable: $1,159,000,000.00Pharmacy and other service costs payable+$1.16 BReinsurance recoverable and Other assets: $201,000,000.00Reinsurance recoverables+$201.00 MLoss on sale of businesses: $87,000,000.00Business sale gain & loss+$87.00 MNet cash from operating activities: $46,000,000.00Operating cash+$46.00 MOperating adjustments reconciliation: $4,332,000,000.00Net change in short-term debt: $833,000,000.00Net change in short-term debt+$833.00 MNet proceeds on issuance of long-term debt: $0.00Repayment of long-term debt: $0.00Other, net: -$57,000,000.00Other financing, net−$57.00 MWithdrawals and benefit payments from contractholder deposit funds: -$45,000,000.00Policyholder withdrawals−$45.00 MRepurchase of common stock: $0.00Common stock dividend paid: -$390,000,000.00Common dividends paid−$390.00 MIssuance of common stock: $62,000,000.00Common stock issued+$62.00 MDeposits and interest credited to contractholder deposit funds: $36,000,000.00Policyholder deposits+$36.00 MNet cash from financing activities: $439,000,000.00Financing cash+$439.00 Mfinancing reconciliation: $931,000,000.00Debt securities and equity securities: $176,000,000.00Debt securities and equity securities+$176.00 MAcquisitions, net of cash acquired: -$132,000,000.00Acquisitions, net of cash−$132.00 MOther sales, maturities and repayments (primarily short-term and other long-term investments): $116,000,000.00Other investment proceeds+$116.00 MOther (primarily short-term and other long-term investments): -$163,000,000.00Other investment purchases−$163.00 MOther, net: -$135,000,000.00Other investing, net−$135.00 MCommercial mortgage loans: -$2,000,000.00Mortgage note purchases−$2.00 MDebt securities and equity securities: $171,000,000.00Debt securities and equity securities+$171.00 MDivestitures, net of cash sold: $0.00Debt securities and equity securities: -$450,000,000.00Debt securities and equity securities−$450.00 MProperty and equipment purchases, net: -$399,000,000.00Property and equipment purchases, net−$399.00 MCommercial mortgage loans: $42,000,000.00Loan collections+$42.00 MNet cash used in investing activities: -$776,000,000.00. Cash required to fund net payments.Investing cash−$776.00 Minvesting reconciliation: $1,281,000,000.00Cash sources and uses: $7,960,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $7,457,000,000.00Beginning cash$7.46 BEnding cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $7,184,000,000.00Ending cash$7.18 BExchange-rate effect: $18,000,000.00FX effect+$18.00 MCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsFree cash flowNot availableCash flow / Net income0.06×Operating cash flow ÷ net incomeNet cash change−$273.00 MEnding cash − beginning cash
Chart details

The Cigna Group cash flow reconciliation, Jul 1, 2024 through Sep 30, 2024

Cash flows for Jul 1, 2024 through Sep 30, 2024. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Jun 30, 2024. Ending cash: Sep 30, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Jun 30, 2024
7,457,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Operating activities
46,000,000 US dollars. Net cash provided.
Other, net
430,000,000 US dollars
Accounts payable and Accrued expenses and other liabilities
negative 804,000,000 US dollars
Deferred income tax benefit
negative 152,000,000 US dollars
Depreciation and amortization
650,000,000 US dollars
Inventories
105,000,000 US dollars
Net income
825,000,000 US dollars
Insurance liabilities
negative 89,000,000 US dollars
Accounts receivable, net
negative 3,287,000,000 US dollars
Realized investment losses, net
921,000,000 US dollars
Pharmacy and other service costs payable
1,159,000,000 US dollars
Reinsurance recoverable and Other assets
201,000,000 US dollars
Loss on sale of businesses
87,000,000 US dollars
Investing activities
negative 776,000,000 US dollars. Net cash used.
Debt securities and equity securities
176,000,000 US dollars
Acquisitions, net of cash acquired
negative 132,000,000 US dollars
Other sales, maturities and repayments (primarily short-term and other long-term investments)
116,000,000 US dollars
Other (primarily short-term and other long-term investments)
negative 163,000,000 US dollars
Other, net
negative 135,000,000 US dollars
Commercial mortgage loans
negative 2,000,000 US dollars
Debt securities and equity securities
171,000,000 US dollars
Divestitures, net of cash sold
0 US dollars
Debt securities and equity securities
negative 450,000,000 US dollars
Property and equipment purchases, net
negative 399,000,000 US dollars
Commercial mortgage loans
42,000,000 US dollars
Financing activities
439,000,000 US dollars. Net cash provided.
Net change in short-term debt
833,000,000 US dollars
Net proceeds on issuance of long-term debt
0 US dollars
Repayment of long-term debt
0 US dollars
Other, net
negative 57,000,000 US dollars
Withdrawals and benefit payments from contractholder deposit funds
negative 45,000,000 US dollars
Repurchase of common stock
0 US dollars
Common stock dividend paid
negative 390,000,000 US dollars
Issuance of common stock
62,000,000 US dollars
Deposits and interest credited to contractholder deposit funds
36,000,000 US dollars
Operating adjustment reconciliation
4,332,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
931,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
1,281,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
18,000,000 US dollars
Ending cash on Sep 30, 2024
7,184,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Cash sources and uses
7,960,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 273,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.06×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $46.00M of net income directly to operating cash and $779.00M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
The Cigna Group (CI) FY2024 Q3 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!